跳至主要内容
临床试验/NCT02208388
NCT02208388招募中不适用

Prospective Evaluation of MyocaRdial PerFUSion ComputEd Tomography Trial: Ischemia-guided Revascularization Using Perfusion Coronary CT vs. Fractional Flow Reserve

Young-Hak Kim, MD, PhD7 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2014年8月12日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,000
试验地点
7
主要终点
Composite Events

研究概览

简要总结

The purpose of this study is to evaluate safety and effectiveness of CTP(computed tomography perfusion) guided revascularization vs FFR(Fractional flow reserve) guided revascularization

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 20 and more
  • Diagnosed angina or angina equivalent symptom or positive exercise treadmill test
  • Patients with intermediate- or high-risk probability of CAD defined by Diamond and Forester
  • 70 % stenosis or more in coronary CTA
  • Willing to provide informed, written consent

排除标准

  • Requirement for surgical procedure
  • Cardiogenic shock and/or need for mechanical/pharmacologic hemodynamic support
  • Recent STEMI (<5 days)
  • Non STEMI, if the cardiac troponin is not stable or starting to decline
  • Left ventricular ejection fraction <30%
  • Life expectancy <2 years
  • Impaired renal function with an effective glomerular filtration rate less than 30mL/min/1.73 ㎡ or creatinine more than 2.0 mg/dL
  • Undergoing evaluation for organ transplantation
  • Participation or planned participation in another cardiovascular clinical trial
  • Pregnancy
  • Inability to take dual antiplatelet therapy for six months
  • Previous CABG
  • Left main disease requiring revascularization
  • Any target lesion with in-stent restenosis
  • NYHA class 3 or 4a
  • Severe and persistent angina with severe limitation in everyday living activities (Canadian Cardiovascular Society grading Class IV)

结局指标

主要结局

Composite Events

时间窗: 1 year

All cause death, Myocardial infarction, Diseased-related unplanned hospitalization or stroke

次要结局

  • Myocardial infarction(5 year)
  • Target vessel revascularization(5 year)
  • All cause death(5 year)
  • Seattle Angina Questionnaire,EQ5D questionnaire(5 year)
  • Success of intervention(5 year)
  • Stent thrombosis(5 year)
  • Cost effective analysis(1 year)

研究者

发起方
Young-Hak Kim, MD, PhD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Young-Hak Kim, MD, PhD

MD

Asan Medical Center

研究点 (7)

Loading locations...

相似试验